Page last updated: 2024-12-10
rosanol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
rosanol: from Bulgarian rose oil; contains added geraniol [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 3017432 |
| SCHEMBL ID | 111930 |
| MeSH ID | M0058731 |
Synonyms (26)
| Synonym |
|---|
| 2-(isobutyl)-4-hydroxy-4-methyl tetrahydropyran |
| 4-methyl-2-(2-methylpropyl)oxan-4-ol |
| AKOS006274936 |
| ec 405-040-6 |
| 2-isobutyl-4-methyltetrahydropyran-4-ol |
| vk5zhh2t3f , |
| rosanol |
| 2h-pyran-4-ol, tetrahydro-4-methyl-2-(2-methylpropyl)- |
| rozanol |
| unii-vk5zhh2t3f |
| 63500-71-0 |
| AM806733 |
| FT-0618626 |
| 4-hydroxy-4-methyl-2-(2-methylpropyl)tetrahydropyran |
| 2-(2-methylpropyl)-4-hydroxy-4-methyltetrahydropyran |
| florosa |
| isobutyl methyl tetrahydropyranol [inci] |
| isobutyl methyl tetrahydropyranol |
| SCHEMBL111930 |
| 2-isobutyl-4-methyltetrahydro-2h-pyran-4-ol |
| DTXSID2052318 |
| 2-isobutyl-4-hydroxy-4-methyltetrahydropyran |
| YVSNOTITPICPTB-UHFFFAOYSA-N |
| 2h-pyran-4-ol, tetrahydro-4-methyl-2-(2-methylpropyl) |
| 2h-pyran-4-ol,tetrahydro-4-methyl-2-(2-methylpropyl)- |
| Q27291866 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 25.56
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (25.56) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (16.67%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (83.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||